Shrinking lungs syndrome in systemic lupus erythematosus: improvement with inhaled beta-agonist therapy.

Abstract:

:The pathogenesis and therapy of shrinking lungs syndrome in patients with systemic lupus erythematosus remains controversial. It has been previously reported that corticosteroid treatment can be effective. We report a patient with shrinking lungs syndrome who presented a good response to inhaled beta-agonist therapy. Therapeutic approach to this syndrome is discussed.

journal_name

Lupus

journal_title

Lupus

authors

Muñoz-Rodríguez FJ,Font J,Badia JR,Miret C,Barberà JA,Cervera R,Ingelmo M

doi

10.1177/096120339700600413

subject

Has Abstract

pub_date

1997-01-01 00:00:00

pages

412-4

issue

4

eissn

0961-2033

issn

1477-0962

journal_volume

6

pub_type

杂志文章

相关文献

LUPUS文献大全
  • Entheseal involvement in systemic lupus erythematosus: are we missing something?

    abstract::Background Musculoskeletal involvement is extremely common in patients with systemic lupus erythematosus (SLE). Continuing the research initiated in patients with inflammatory arthritis, recent studies have shown the potential role of musculoskeletal ultrasound (MSUS) in the evaluation of clinical and subclinical lupu...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1177/0961203316662723

    authors: Di Matteo A,Satulu I,Di Carlo M,Lato V,Filippucci E,Grassi W

    更新日期:2017-03-01 00:00:00

  • Mycophenolate mofetil as a maintenance therapy for lupus-related diffuse alveolar hemorrhage: a case report.

    abstract::Diffuse alveolar hemorrhage (DAH) is a life-threatening complication of systemic lupus erythematosus (SLE). Cases complicated with DAH often have active SLE with multi-organ involvement, especially lupus nephritis. We describe a rare case of DAH as the first presenting manifestation of SLE in the absence of lupus neph...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1177/0961203311411353

    authors: Al Rashidi A,Alajmi M,Hegazi MO

    更新日期:2011-12-01 00:00:00

  • Depression and systemic lupus erythematosus: a systematic review.

    abstract:OBJECTIVE:Systemic lupus erythematosus (SLE) is a chronic, relapsing-remitting autoimmune disorder that involves multiple organ systems including the central nervous system. Among the items included in the nomenclature for neuropsychiatric SLE, mood disorders have been identified. The aim of this paper is to review the...

    journal_title:Lupus

    pub_type: 杂志文章,评审

    doi:10.1177/0961203313477227

    authors: Palagini L,Mosca M,Tani C,Gemignani A,Mauri M,Bombardieri S

    更新日期:2013-04-01 00:00:00

  • A case of drug-induced lupus erythematosus secondary to trimethoprim/sulfamethoxazole presenting with pleural effusions and pericardial tamponade.

    abstract::We report a case of drug-induced lupus erythematosus (DILE) secondary to trimethoprim/sulfamethoxazole (TMP/SMX) in a patient with underlying inflammatory bowel disease (IBD). The initial presentation was with febrile pleural and pericardial effusions followed by cardiac tamponade. The patient was treated with a short...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1177/0961203316657435

    authors: Jose A,Cramer AK,Davar K,Gutierrez G

    更新日期:2017-03-01 00:00:00

  • Use of monoclonal antibodies to dissect specificity and pathogenesis of antiphospholipid antibodies.

    abstract::Monoclonal antiphospholipid antibodies (aPL) have been utilized to dissect the relationship between their sequence, structure, binding and biological properties relevant to the pathogenesis of the antiphospholipid syndrome. In particular, sequence analysis of aPL has highlighted the clustering of certain amino acid re...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1177/0961203309360809

    authors: Lambrianides A,Giles IP

    更新日期:2010-04-01 00:00:00

  • Intestinal pseudo-obstruction syndrome in systemic lupus erythematosus.

    abstract::Intestinal pseudo-obstruction (IpsO) occurs in a small subgroup of patients with systemic lupus erythematosus (SLE), and has been under-recognized. The etiology and mechanisms are unclear. Herein, we report two cases. In case 1, IpsO occurred as the complication in a previously diagnosed SLE patient. In case 2, IpsO w...

    journal_title:Lupus

    pub_type: 杂志文章,评审

    doi:10.1177/0961203311405702

    authors: Zhang J,Fang M,Wang Y,Mao J,Sun X

    更新日期:2011-10-01 00:00:00

  • Associations of four common VDR polymorphisms with rheumatoid arthritis and systemic lupus erythematosus: evidence from a meta-analysis.

    abstract::Associations of polymorphisms in vitamin D receptor (VDR) with rheumatoid arthritis (RA) and systemic lupus erythematosus (SLE) have already been explored by many studies. The aim of this meta-analysis was to better clarify associations between polymorphisms in VDR and RA/SLE by combing the results of all relevant stu...

    journal_title:Lupus

    pub_type: 杂志文章,meta分析

    doi:10.1177/0961203320909432

    authors: Zhang WT,Jin TF,Chen L

    更新日期:2020-04-01 00:00:00

  • Frequency of antibodies to the cholesterol transport protein apolipoprotein A1 in patients with SLE.

    abstract::In examining reasons for premature atherosclerosis in systemic lupus erythematosus (SLE), we previously reported low levels of the cholesterol transport protein apolipoprotein A1 (apoA1) in these patients, and specific antibodies to purified apoA1 were identified in the sera of 5 out of 30 lupus patients. The current ...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1191/096120398678920262

    authors: Dinu AR,Merrill JT,Shen C,Antonov IV,Myones BL,Lahita RG

    更新日期:1998-01-01 00:00:00

  • Improvement in health-related quality of life in systemic lupus erythematosus patients enrolled in a randomized clinical trial comparing LJP 394 treatment with placebo.

    abstract::In a 76-week, randomized controlled trial, patients received 100 mg LJP 394 or placebo weekly for 16 weeks followed by three 12-week treatment cycles of 50 mg LJP 394 or placebo weekly each separated by eight-week periods when no therapy was administered. Health-related quality of life (HRQOL) was assessed using SF-36...

    journal_title:Lupus

    pub_type: 临床试验,杂志文章,多中心研究,随机对照试验

    doi:10.1191/0961203303lu440oa

    authors: Strand V,Aranow C,Cardiel MH,Alarcón-Segovia D,Furie R,Sherrer Y,Tumlin J,Wallace DJ,Crawford B,LJP 394 Investigator Consortium.

    更新日期:2003-01-01 00:00:00

  • Association of Asian ethnicity with disease activity in SLE: an observational study from the Monash Lupus Clinic.

    abstract:OBJECTIVE:Systemic lupus erythematosus (SLE), an autoimmune condition with diverse clinical manifestations, is reported to have different expression in populations of different ancestry. Most previous studies compared patients of different ethnic groups from geographically distinct cohorts. In our study, we aimed to ch...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1177/0961203313500547

    authors: Golder V,Connelly K,Staples M,Morand E,Hoi A

    更新日期:2013-11-01 00:00:00

  • Lupus nephritis in Croatian children: clinicopathologic findings and outcome.

    abstract::We report clinical and histopathological features, treatment and outcome of 37 Croatian children with biopsy-proven lupus nephritis seen over a 30-year period. The mean age at lupus nephritis presentation was 12.11 ± 2.59 years (range 4.66-17.0). The most frequent histopathological finding was class IV (37.8%), follow...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1177/0961203314563133

    authors: Batinić D,Milošević D,Čorić M,Topalović-Grković M,Jelušić M,Turudić D

    更新日期:2015-03-01 00:00:00

  • Advanced MRI techniques: biomarkers in neuropsychiatric lupus.

    abstract::Objectives The objective of this study was to determine whether advanced MRI could provide biomarkers for diagnosis and prognosis in neuropsychiatric systemic lupus erythematosus (NPSLE). Methods Our prospective study included 28 systemic lupus erythematosus (SLE) patients with primary central NPSLE, 22 patients witho...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1177/0961203316674820

    authors: Sarbu N,Toledano P,Calvo A,Roura E,Sarbu MI,Espinosa G,Lladó X,Cervera R,Bargalló N

    更新日期:2017-04-01 00:00:00

  • Prolactin levels in patients with systemic lupus erythematosus: a case controlled study.

    abstract::Recent accumulated evidence suggests that prolactin (PRL) is an important immunomodulator and might have a role in the pathogenesis of systemic lupus erythematosus (SLE). Our aim was to assess the frequency of hyperprolactinemia in women with SLE and to evaluate its correlation with disease activity. PRL plasma levels...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1191/096120398678920361

    authors: Jimena P,Aguirre MA,López-Curbelo A,de Andrés M,Garcia-Courtay C,Cuadrado MJ

    更新日期:1998-01-01 00:00:00

  • Libman-Sacks endocarditis in the antiphospholipid syndrome: immunopathologic findings in deformed heart valves.

    abstract:OBJECTIVE:To examine the potential immunologic mechanism and involvement of antiphospholipid antibodies in the pathogenesis of heart valve lesions in patients with the antiphospholipid syndrome (APS). METHODS:Immunoperoxidase and immunofluorescence staining methods were used to evaluate 13 heart valve specimens derive...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1177/096120339600500306

    authors: Ziporen L,Goldberg I,Arad M,Hojnik M,Ordi-Ros J,Afek A,Blank M,Sandbank Y,Vilardell-Tarres M,de Torres I,Weinberger A,Asherson RA,Kopolovic Y,Shoenfeld Y

    更新日期:1996-06-01 00:00:00

  • Non-stroke neurological syndromes associated with antiphospholipid antibodies: evaluation of clinical and experimental studies.

    abstract::Although many types of neurological disorders and events have been described in association with antiphospholipid antibodies (aPL) and the antiphospholipid syndrome (APS), only ischaemic stroke is reasonably well established and accepted as a diagnostic criterion for the syndrome. We propose to evaluate, classify and ...

    journal_title:Lupus

    pub_type: 共识发展会议,杂志文章,评审

    doi:10.1191/0961203303lu392oa

    authors: Chapman J,Rand JH,Brey RL,Levine SR,Blatt I,Khamashta MA,Shoenfeld Y

    更新日期:2003-01-01 00:00:00

  • Objectively measured physical activity and its influence on physical capacity and clinical parameters in patients with primary Sjögren's syndrome.

    abstract::Objective The objectives of this paper are to objectively measure habitual physical activity levels in patients with primary Sjögren's syndrome (pSS) with mild disease activity and to determine to which extent it may be associated with physical capacity and function and clinical features. Methods In this cross-section...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1177/0961203316674819

    authors: Dassouki T,Benatti FB,Pinto AJ,Roschel H,Lima FR,Augusto K,Pasoto S,Pereira RMR,Gualano B,de Sá Pinto AL

    更新日期:2017-06-01 00:00:00

  • Antimalarials as a risk factor for elevated muscle enzymes in systemic lupus erythematosus.

    abstract:OBJECTIVE:To investigate the relationship between antimalarials (AM) and elevated muscle enzymes in systemic lupus erythematosus (SLE). PATIENTSMETHODS:325 lupus patients with abnormal creatine phosphokinase (CPK) for at least two consecutive clinic visits were enrolled; 54 patients on statins/fibrates (n = 43) and/or...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1177/0961203315617845

    authors: Tselios K,Gladman DD,Su J,Urowitz MB

    更新日期:2016-04-01 00:00:00

  • Using the GRADE system in diagnostic strategy: the case of antiphospholipid syndrome.

    abstract::Diagnostic strategy studies commonly focus on the accuracy of tests in diagnosing, and grading this body of evidence is a challenge in itself because (1) standard tools for grading evidence were designed for questions about treatment rather than diagnostic testing; and (2) the clinical usefulness of a diagnostic strat...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1177/0961203314543922

    authors: Mendes de Abreu M,Levy RA,Wahl D

    更新日期:2014-10-01 00:00:00

  • The illness experience of youth with lupus/mixed connective tissue disease: a mixed methods analysis of patient and parent perspectives.

    abstract:OBJECTIVE:We aimed to develop a model of the illness experience for youth with systemic lupus erythematosus (SLE)/mixed connective tissue disease (MCTD). METHODS:We conducted 32 semi-structured interviews with 16 outpatient youth with SLE/MCTD, age 11 to 22 years, and their parents. We qualitatively defined key featur...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1177/0961203316646460

    authors: Knight A,Vickery M,Fiks AG,Barg FK

    更新日期:2016-08-01 00:00:00

  • Swallowing disturbance due to isolated vagus nerve involvement in systemic lupus erythematosus.

    abstract::Neuropsychiatric lupus is a well-recognized complication of systemic lupus erythematosus (SLE) and encompasses a wide variety of neurological manifestations. Although isolated cranial nerve involvement is rare, it can cause significant morbidity and disability. This report describes a case with isolated vagus nerve in...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1177/0961203307080632

    authors: Yu KH,Yang CH,Chu CC

    更新日期:2007-01-01 00:00:00

  • In vitro modulation of anti-DNA secreting peripheral blood mononuclear cells of lupus patients by anti-idiotypic antibody of pooled human intravenous immune globulin.

    abstract::Anti-idiotypic antibody and its F(ab')2 fragments prepared from pooled normal human IgG had a partial inhibitory effect on the spontaneous in vitro secretion of anti-DNA antibodies from blood mononuclear cells of lupus patients. The inhibitory effect was specific for anti-DNA secretion as the anti-idiotype failed to i...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1177/096120339300200607

    authors: Evans M,Abdou NI

    更新日期:1993-12-01 00:00:00

  • Annexin A2: biology and relevance to the antiphospholipid syndrome.

    abstract::Antiphospholipid antibodies (aPL), the majority of which are directed against beta(2)-glycoprotein I (beta(2)GPI), are associated with an increased incidence of venous and arterial thrombosis. The pathogenesis of antiphospholipid/anti-beta(2)GPI-associated thrombosis has not been defined, and is likely multifactorial....

    journal_title:Lupus

    pub_type: 杂志文章,评审

    doi:10.1177/0961203308095329

    authors: Cockrell E,Espinola RG,McCrae KR

    更新日期:2008-10-01 00:00:00

  • A case of toxic epidermal necrolysis-like skin lesions with systemic lupus erythematosus and review of the literature.

    abstract:OBJECTIVE:Subepidermal bullous lesions and toxic epidermal necrolysis-like (TEN-like) lesions can occur in patients with systemic lupus erythematosus (SLE). In this report, we describe a case of a patient previously diagnosed with SLE who experienced TEN-like skin lesions with unusual subacute progression in the contex...

    journal_title:Lupus

    pub_type: 杂志文章,评审

    doi:10.1177/0961203313492242

    authors: Yildirim Cetin G,Sayar H,Ozkan F,Kurtulus S,Kesici F,Sayarlioglu M

    更新日期:2013-07-01 00:00:00

  • Pathogenesis of the antiphospholipid antibody syndrome.

    abstract::Endothelial and/or platelet activation likely initiates thrombus formation. Whether antiphospholipid antibody (aPL) is an activator, a toxic response, or a protective response is not clear, nor is it certain whether aPL is germ-line encoded or antigen-driven. The pregnancy model is particularly informative. Alternativ...

    journal_title:Lupus

    pub_type: 杂志文章,评审

    doi:10.1177/096120339600500514

    authors: Lockshin MD

    更新日期:1996-10-01 00:00:00

  • Profiles of cytokines (TNF alpha and IL-6) and acute phase proteins (CRP and alpha 1AG) related to the disease course in patients with systemic lupus erythematosus.

    abstract::Tumor necrosis factor alpha (TNF alpha) and interleukin-6 (IL-6) play a main role in inducing acute phase protein production by hepatocytes. This study describes the serum levels of TNF alpha and IL-6 in relation to serum levels of C-reactive protein (CRP) and alpha 1-acid glycoprotein (alpha 1AG) in three systemic lu...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1177/096120339300200605

    authors: Meijer C,Huysen V,Smeenk RT,Swaak AJ

    更新日期:1993-12-01 00:00:00

  • Expression of complement regulatory proteins in diffuse proliferative glomerulonephritis.

    abstract::This study assessed the expression of complement receptor 1 (CR1), decay accelerating factor (DAF) and membrane inhibitor of reactive lysis (CD59) on the erythrocytes and glomerulus of diffuse proliferative glomerulonephritis (DPGN) of systemic lupus erythematosus (SLE) patients using flow cytometry and immunofluoresc...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1191/096120300678828154

    authors: Arora M,Arora R,Tiwari SC,Das N,Srivastava LM

    更新日期:2000-01-01 00:00:00

  • Double-blind, randomized, placebo-controlled pilot study of leflunomide in systemic lupus erythematosus.

    abstract::Twelve systemic lupus erythematosus (SLE) patients with mild to moderate disease activity (SLEDAI of > or = 6 and on prednisolone < 0.5 mg/kg/day) were included in a prospective, randomized, double-blind, placebo-controlled pilot study for 24 weeks. Six were randomized to receive oral leflunomide and six received plac...

    journal_title:Lupus

    pub_type: 临床试验,杂志文章,随机对照试验

    doi:10.1191/0961203304lu1067sr

    authors: Tam LS,Li EK,Wong CK,Lam CW,Szeto CC

    更新日期:2004-01-01 00:00:00

  • Antiphospholipid syndrome and tissue factor: a thrombotic couple.

    abstract::The antiphospholipid syndrome (APS) is characterized by thrombosis and/or pregnancy morbidity in the presence of antiphospholipid antibodies (aPL). Among the thrombogenic mechanisms proposed, it has been suggested that aPL can stimulate tissue factor (TF) expression by endothelial cells (ECs) and monocytes. Moreover, ...

    journal_title:Lupus

    pub_type: 杂志文章,评审

    doi:10.1191/0961203306lu2276rr

    authors: López-Pedrera Ch,Buendía P,Aguirre MA,Velasco F,Cuadrado MJ

    更新日期:2006-01-01 00:00:00

  • Carotid intima-media thickness and arterial stiffness in pediatric systemic lupus erythematosus.

    abstract::Objectives The carotid intima-media thickness (CIMT) and carotid arterial stiffness index (CASI) act as the surrogate markers of atherosclerosis. We aim to assess CIMT and CASI in pediatric systemic lupus erythematosus (SLE). Methods Patients ≤ 20 years old fulfilling diagnostic criteria for SLE were enrolled. Patient...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1177/0961203317692434

    authors: Su-Angka N,Khositseth A,Vilaiyuk S,Tangnararatchakit K,Prangwatanagul W

    更新日期:2017-08-01 00:00:00

  • Hypocomplementemia in systemic lupus erythematosus and primary antiphospholipid syndrome: prevalence and clinical significance in 667 patients.

    abstract::The objective of the study was to analyse the prevalence and clinical significance of hypocomplementemia in a large series of patients diagnosed either with systemic lupus erythematosus (SLE) or with primary antiphospholipid syndrome (APS) and its association with the main clinical, hematological and immunological fea...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1191/0961203304lu1080oa

    authors: Ramos-Casals M,Campoamor MT,Chamorro A,Salvador G,Segura S,Botero JC,Yagüe J,Cervera R,Ingelmo M,Font J

    更新日期:2004-01-01 00:00:00